chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Rash, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Rash on left side of the body.; Hot burning sensation; Muscle is tender to touch; Itching in torso, back area; Itching started couple days after near injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in torso, back area), VACCINATION SITE PRURITUS (Itching started couple days after near injection site), RASH (Rash on left side of the body.), VACCINATION SITE PAIN (Hot burning sensation) and MYALGIA (Muscle is tender to touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREGABALIN (LYRICA) and HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PRURITUS (Itching in torso, back area), VACCINATION SITE PRURITUS (Itching started couple days after near injection site), VACCINATION SITE PAIN (Hot burning sensation) and MYALGIA (Muscle is tender to touch). On an unknown date, the patient experienced RASH (Rash on left side of the body.). The patient was treated with PREDNISONE for Itching and Rash, at a dose of UNK dosage form. At the time of the report, PRURITUS (Itching in torso, back area) had not resolved and VACCINATION SITE PRURITUS (Itching started couple days after near injection site), RASH (Rash on left side of the body.), VACCINATION SITE PAIN (Hot burning sensation) and MYALGIA (Muscle is tender to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pyrexia, Rash, Somnolence
Clinical narrative: Felt horrible; In and out of sleep; Rash on her back side; Fever; Chillls; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls). At the time of the report, ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: Constantly sleeping; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Constantly sleeping) and FATIGUE (feeling tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced HYPERSOMNIA (Constantly sleeping) and FATIGUE (feeling tired). At the time of the report, HYPERSOMNIA (Constantly sleeping) and FATIGUE (feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch circle at the site of injection; Itchy circle at the site of injection; Red circle at the site of injection; Sore circle at the site of injection; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Swelling
Clinical narrative: Axillary gland is swelling; Achiness; Fever; Arm soreness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), SWELLING (Axillary gland is swelling), PAIN (Achiness) and PYREXIA (Fever) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), PAIN (Achiness) and PYREXIA (Fever). On 11-Feb-2021, the patient experienced SWELLING (Axillary gland is swelling). At the time of the report, PAIN IN EXTREMITY (Arm soreness), SWELLING (Axillary gland is swelling), PAIN (Achiness) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   It was reported that, on 11-Feb-2021, the patient noticed that his axillary gland was swollen, and has progressively been swelling.  No corrective treatment was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Tenderness
Clinical narrative: tenderness; rash at the injection site; itchy, redness; swelling and tenderness; itchy; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), INJECTION SITE RASH (rash at the injection site), INJECTION SITE ERYTHEMA (itchy, redness), INJECTION SITE SWELLING (swelling and tenderness) and INJECTION SITE PRURITUS (itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS and CANNABIDIOL (CBD OIL) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced TENDERNESS (tenderness), INJECTION SITE RASH (rash at the injection site), INJECTION SITE ERYTHEMA (itchy, redness), INJECTION SITE SWELLING (swelling and tenderness) and INJECTION SITE PRURITUS (itchy). At the time of the report, TENDERNESS (tenderness), INJECTION SITE RASH (rash at the injection site), INJECTION SITE ERYTHEMA (itchy, redness), INJECTION SITE SWELLING (swelling and tenderness) and INJECTION SITE PRURITUS (itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received second and did not experience any adverse events. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up received on 23-APR-2021, updated outcome of the events from unknown to recovered.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: severe headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache) and ARTHRALGIA (joint pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HEADACHE (severe headache) and ARTHRALGIA (joint pain). At the time of the report, HEADACHE (severe headache) and ARTHRALGIA (joint pain) outcome was unknown.            Concomitant medications were not provided. Treatment details were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Movement disorder
Clinical narrative: Couldn't move from one side of the bed to the next couldn't move; Sick; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (Couldn't move from one side of the bed to the next couldn't move), ILLNESS (Sick) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOVEMENT DISORDER (Couldn't move from one side of the bed to the next couldn't move), ILLNESS (Sick) and CHILLS (Chills). At the time of the report, MOVEMENT DISORDER (Couldn't move from one side of the bed to the next couldn't move), ILLNESS (Sick) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided. treatment to the events not reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: missed the 42 day window; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed the 42 day window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed the 42 day window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed the 42 day window) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. patient missed second dose due to the snow storms.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was just sore the following day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was just sore the following day) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was just sore the following day). At the time of the report, PAIN IN EXTREMITY (Arm was just sore the following day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On 27 Feb 2021, the patient received second dose of mRNA-1273 (Lot number: 012A21A) via unknown route in the right dominant arm for prophylaxis of COVID-19 infection.  No concomitant medications were reported. Treatment details was not provided.   This case was linked to MOD-2021-059392 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Hyperhidrosis, Nausea, Peripheral swelling
Clinical narrative: heat in the chest during administration; increased tachycardia; swollen legs; shaking; Dizziness; Sweating; low grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking) and DIZZINESS (Dizziness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of 1 dosage form. At the time of the report, CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    Reporter did not allow further contact
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia, Tremor
Clinical narrative: heat in the chest during administration; increased tachycardia; swollen legs; shaking; Dizziness; Sweating; low grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking) and DIZZINESS (Dizziness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of 1 dosage form. At the time of the report, CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Hyperhidrosis, Vomiting
Clinical narrative: Severe sweating; Stomach cramps; Diarrhea; Severe chills; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Severe sweating), ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea), CHILLS (Severe chills) and VOMITING (Vomiting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HYPERHIDROSIS (Severe sweating), ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea), CHILLS (Severe chills) and VOMITING (Vomiting). At the time of the report, HYPERHIDROSIS (Severe sweating), ABDOMINAL PAIN UPPER (Stomach cramps), DIARRHOEA (Diarrhea), CHILLS (Severe chills) and VOMITING (Vomiting) had not resolved.            Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 07-Feb-2021, VACCINATION SITE PAIN (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   This case was linked to MOD-2021-035330 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cystitis, Diarrhoea, Myalgia, Nausea
Clinical narrative: low grade fever of 99.1 degrees F; nausea; diarrhea; joints hurt; Bladder infection; Covid-19 positive test result; sore arm; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CYSTITIS (Bladder infection), SARS-COV-2 TEST POSITIVE (Covid-19 positive test result), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches) and PYREXIA (low grade fever of 99.1 degrees F) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and MYALGIA (body aches). On 05-Mar-2021, the patient experienced CYSTITIS (Bladder infection) and SARS-COV-2 TEST POSITIVE (Covid-19 positive test result). On an unknown date, the patient experienced PYREXIA (low grade fever of 99.1 degrees F), NAUSEA (nausea), DIARRHOEA (diarrhea) and ARTHRALGIA (joints hurt). At the time of the report, CYSTITIS (Bladder infection), SARS-COV-2 TEST POSITIVE (Covid-19 positive test result), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches), PYREXIA (low grade fever of 99.1 degrees F), NAUSEA (nausea), DIARRHOEA (diarrhea) and ARTHRALGIA (joints hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: low grade fever of 99.1 degrees F; nausea; diarrhea; joints hurt; Bladder infection; Covid-19 positive test result; sore arm; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CYSTITIS (Bladder infection), SARS-COV-2 TEST POSITIVE (Covid-19 positive test result), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches) and PYREXIA (low grade fever of 99.1 degrees F) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and MYALGIA (body aches). On 05-Mar-2021, the patient experienced CYSTITIS (Bladder infection) and SARS-COV-2 TEST POSITIVE (Covid-19 positive test result). On an unknown date, the patient experienced PYREXIA (low grade fever of 99.1 degrees F), NAUSEA (nausea), DIARRHOEA (diarrhea) and ARTHRALGIA (joints hurt). At the time of the report, CYSTITIS (Bladder infection), SARS-COV-2 TEST POSITIVE (Covid-19 positive test result), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches), PYREXIA (low grade fever of 99.1 degrees F), NAUSEA (nausea), DIARRHOEA (diarrhea) and ARTHRALGIA (joints hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (mild fever), chills and headache in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 002A21A) for COVID-19 immunization. No medical history reported. On Feb 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 3, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 4, 2021, patient experienced pyrexia (mild fever), chills and headache. The patient treated with Tylenol (paracetamol) for headache, 1 dosage form. At the time of the report, pyrexia (mild fever), chills and headache resolved. Patient stated she had reactive lymph nodes. No concomitant medications reported. This case linked to MOD-2021-035328 (patient link). Most recent follow-up information incorporated above included: On Apr 30, 2021: Event resolved.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site induration, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (slight hardness), VACCINATION SITE PAIN (slight pain) and PYREXIA (low grade temperature) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METFORMIN and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE INDURATION (slight hardness), VACCINATION SITE PAIN (slight pain) and PYREXIA (low grade temperature). At the time of the report, VACCINATION SITE INDURATION (slight hardness), VACCINATION SITE PAIN (slight pain) and PYREXIA (low grade temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 95.4 (Low) She was having lower than normal temperature and 96.2 (Inconclusive) One hour later it was 96.2 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include OTC-Emergen-C.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Arm is sore; Fatigue; Headache; Chills; Muscle pain; Joint pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Muscle pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.  Patient gave consent to safety for Follow-up.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm is sore; Fatigue; Headache; Chills; Muscle pain; Joint pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Muscle pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm is sore), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.  Patient gave consent to safety for Follow-up.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm pain). On 03-Feb-2021, VACCINATION SITE PAIN (arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.  Patient gave consent to safety for Follow-up.   This case was linked to MOD-2021-035340 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: Lips and tongue were numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips and tongue were numb) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (Lips and tongue were numb). At the time of the report, HYPOAESTHESIA ORAL (Lips and tongue were numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itchy; Rash; swelling on injection area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (swelling on injection area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (swelling on injection area). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (swelling on injection area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Injection site reaction, Rash macular
Clinical narrative: twelve little red spots; bright and dark red bumps; twelve little red spots; bright and dark red bumps; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (twelve little red spots; bright and dark red bumps) and INJECTION SITE REACTION (twelve little red spots; bright and dark red bumps) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Concussion (Patient had five concussions in 1990) in 1990 and Ulcer (Patient had three ulcers). Concurrent medical conditions included Diabetic.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced RASH MACULAR (twelve little red spots; bright and dark red bumps) and INJECTION SITE REACTION (twelve little red spots; bright and dark red bumps). At the time of the report, RASH MACULAR (twelve little red spots; bright and dark red bumps) and INJECTION SITE REACTION (twelve little red spots; bright and dark red bumps) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: unknown (Inconclusive) Patient had a complete physical and his blood work showcased he was doing good health.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Reporter did not allow further contact
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Arm was very very sore; Aching all over my body; Chills; 98.2.F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was very very sore), PAIN (Aching all over my body), CHILLS (Chills) and PYREXIA (98.2.F) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L2DA and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm was very very sore), PAIN (Aching all over my body), CHILLS (Chills) and PYREXIA (98.2.F). At the time of the report, VACCINATION SITE PAIN (Arm was very very sore), PAIN (Aching all over my body), CHILLS (Chills) and PYREXIA (98.2.F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 98.2 98.2F.         No concomitant medication was reported.  Treatment medication was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-230884 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported No relevant medical history was reported.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reactions). At the time of the report, VACCINATION COMPLICATION (Adverse reactions) outcome was unknown.            patient is taking two courses of steroids.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Fatigue, Feeling abnormal, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 28-Feb-2021, the patient experienced COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness), PYREXIA (fever) and FATIGUE (fatigue). On 01-Mar-2021, PAIN (achiness) and PYREXIA (fever) had resolved. At the time of the report, COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad) and FATIGUE (fatigue) outcome was unknown.            Treatment Medications were not provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 28-Feb-2021, the patient experienced COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad), PAIN (achiness), PYREXIA (fever) and FATIGUE (fatigue). On 01-Mar-2021, PAIN (achiness) and PYREXIA (fever) had resolved. At the time of the report, COUGH (dry cough), CHEST DISCOMFORT (chest tightness), FEELING ABNORMAL (feels bad) and FATIGUE (fatigue) outcome was unknown.            Treatment Medications were not provided by the reporter.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Back injury, Back pain, Blood pressure measurement
Clinical narrative: slight back pain; sore neck; nausea; dizzy; neck pain; abdominal pain; felt weak; Headache; Muscle pain; Fever; Back injury; blood pressure was high(195/100); Chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain) and ABDOMINAL PAIN (abdominal pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever). On 01-Mar-2021, the patient experienced DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak) and NAUSEA (nausea). On 04-Mar-2021, the patient experienced BACK PAIN (slight back pain) and NECK PAIN (sore neck). On 26-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak), BACK PAIN (slight back pain), NECK PAIN (sore neck), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement: 195/100 mmHg (High) 195/100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hypertension, Myalgia
Clinical narrative: slight back pain; sore neck; nausea; dizzy; neck pain; abdominal pain; felt weak; Headache; Muscle pain; Fever; Back injury; blood pressure was high(195/100); Chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain) and ABDOMINAL PAIN (abdominal pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever). On 01-Mar-2021, the patient experienced DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak) and NAUSEA (nausea). On 04-Mar-2021, the patient experienced BACK PAIN (slight back pain) and NECK PAIN (sore neck). On 26-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak), BACK PAIN (slight back pain), NECK PAIN (sore neck), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement: 195/100 mmHg (High) 195/100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Pyrexia
Clinical narrative: slight back pain; sore neck; nausea; dizzy; neck pain; abdominal pain; felt weak; Headache; Muscle pain; Fever; Back injury; blood pressure was high(195/100); Chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain) and ABDOMINAL PAIN (abdominal pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant concomitant medications reported No relevant medical history was reported.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever). On 01-Mar-2021, the patient experienced DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak) and NAUSEA (nausea). On 04-Mar-2021, the patient experienced BACK PAIN (slight back pain) and NECK PAIN (sore neck). On 26-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, BACK INJURY (Back injury), HYPERTENSION (blood pressure was high(195/100)), DIZZINESS (dizzy), NECK PAIN (neck pain), ABDOMINAL PAIN (abdominal pain), ASTHENIA (felt weak), BACK PAIN (slight back pain), NECK PAIN (sore neck), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (Muscle pain) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement: 195/100 mmHg (High) 195/100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: feels worse after getting the first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (feels worse after getting the first vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported.  Concurrent medical conditions included Neurological symptoms NOS and Lyme's disease.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (feels worse after getting the first vaccination). At the time of the report, ADVERSE EVENT (feels worse after getting the first vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment Medications were not provided by the reporter.  Upon internal review on 21-May-2021, the age was corrected to unknown.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: Chills; Muscle Pain; Low grade fever of 101°C to 103°C; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Muscle Pain) and PYREXIA (Low grade fever of 101°C to 103°C) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Muscle Pain) and PYREXIA (Low grade fever of 101°C to 103°C). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), MYALGIA (Muscle Pain) and PYREXIA (Low grade fever of 101°C to 103°C) outcome was unknown. Not Related    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 101°c to 103°c (Low) Low grade fever of 101°C to 103°C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medications Ibuprofen.